Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Nøhr MK[au]:

Search results

Items: 21

1.

Gut-associated IgA+ immune cells regulate obesity-related insulin resistance.

Luck H, Khan S, Kim JH, Copeland JK, Revelo XS, Tsai S, Chakraborty M, Cheng K, Tao Chan Y, Nøhr MK, Clemente-Casares X, Perry MC, Ghazarian M, Lei H, Lin YH, Coburn B, Okrainec A, Jackson T, Poutanen S, Gaisano H, Allard JP, Guttman DS, Conner ME, Winer S, Winer DA.

Nat Commun. 2019 Aug 13;10(1):3650. doi: 10.1038/s41467-019-11370-y.

2.

Chronic maternal inflammation or high-fat-feeding programs offspring obesity in a sex-dependent manner.

Dudele A, Hougaard KS, Kjølby M, Hokland M, Winther G, Elfving B, Wegener G, Nielsen AL, Larsen A, Nøhr MK, Pedersen SB, Wang T, Lund S.

Int J Obes (Lond). 2017 Sep;41(9):1420-1426. doi: 10.1038/ijo.2017.136. Epub 2017 Jun 7.

PMID:
28588305
3.

Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Ghazarian M, Revelo XS, Nøhr MK, Luck H, Zeng K, Lei H, Tsai S, Schroer SA, Park YJ, Chng MHY, Shen L, D'Angelo JA, Horton P, Chapman WC, Brockmeier D, Woo M, Engleman EG, Adeyi O, Hirano N, Jin T, Gehring AJ, Winer S, Winer DA.

Sci Immunol. 2017 Apr 21;2(10). pii: eaai7616. doi: 10.1126/sciimmunol.aai7616.

4.

Inflammation Downregulates UCP1 Expression in Brown Adipocytes Potentially via SIRT1 and DBC1 Interaction.

Nøhr MK, Bobba N, Richelsen B, Lund S, Pedersen SB.

Int J Mol Sci. 2017 May 8;18(5). pii: E1006. doi: 10.3390/ijms18051006.

5.

SILAC-MS Based Characterization of LPS and Resveratrol Induced Changes in Adipocyte Proteomics - Resveratrol as Ameliorating Factor on LPS Induced Changes.

Nøhr MK, Kroager TP, Sanggaard KW, Knudsen AD, Stensballe A, Enghild JJ, Ølholm J, Richelsen B, Pedersen SB.

PLoS One. 2016 Jul 20;11(7):e0159747. doi: 10.1371/journal.pone.0159747. eCollection 2016.

6.

A Transporter of Ibuprofen is Upregulated in MDCK I Cells under Hyperosmotic Culture Conditions.

Nielsen CU, Rasmussen RN, Mo J, Noori B, Lagunas C, Holm R, Nøhr MK.

Mol Pharm. 2016 Sep 6;13(9):3119-29. doi: 10.1021/acs.molpharmaceut.6b00330. Epub 2016 Jul 25.

PMID:
27396755
7.

LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol.

Nøhr MK, Dudele A, Poulsen MM, Ebbesen LH, Radko Y, Christensen LP, Jessen N, Richelsen B, Lund S, Pedersen SB.

PLoS One. 2016 Jan 11;11(1):e0146840. doi: 10.1371/journal.pone.0146840. eCollection 2016.

8.

Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.

Grunddal KV, Ratner CF, Svendsen B, Sommer F, Engelstoft MS, Madsen AN, Pedersen J, Nøhr MK, Egerod KL, Nawrocki AR, Kowalski T, Howard AD, Poulsen SS, Offermanns S, Bäckhed F, Holst JJ, Holst B, Schwartz TW.

Endocrinology. 2016 Jan;157(1):176-94. doi: 10.1210/en.2015-1600. Epub 2015 Oct 15.

PMID:
26469136
9.

Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia.

Nøhr MK, Egerod KL, Christiansen SH, Gille A, Offermanns S, Schwartz TW, Møller M.

Neuroscience. 2015 Apr 2;290:126-37. doi: 10.1016/j.neuroscience.2015.01.040. Epub 2015 Jan 28.

PMID:
25637492
10.

Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes.

Poulsen MM, Fjeldborg K, Ornstrup MJ, Kjær TN, Nøhr MK, Pedersen SB.

Biochim Biophys Acta. 2015 Jun;1852(6):1124-36. doi: 10.1016/j.bbadis.2014.12.024. Epub 2015 Jan 9. Review.

11.

Is oral absorption of vigabatrin carrier-mediated?

Nøhr MK, Juul RV, Thale ZI, Holm R, Kreilgaard M, Nielsen CU.

Eur J Pharm Sci. 2015 Mar 10;69:10-8. doi: 10.1016/j.ejps.2014.12.018. Epub 2015 Jan 3.

PMID:
25562534
12.

Intestinal absorption of the antiepileptic drug substance vigabatrin is altered by infant formula in vitro and in vivo.

Nøhr MK, Thale ZI, Brodin B, Hansen SH, Holm R, Nielsen CU.

Pharmacol Res Perspect. 2014 Apr;2(2):e00036. doi: 10.1002/prp2.36. Epub 2014 Mar 24.

13.

Pharmacokinetic aspects of the anti-epileptic drug substance vigabatrin: focus on transporter interactions.

Nøhr MK, Frølund S, Holm R, Nielsen CU.

Ther Deliv. 2014 Aug;5(8):927-42. doi: 10.4155/tde.14.55. Review.

PMID:
25337649
14.

In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport.

Larsen MS, Frølund S, Nøhr MK, Nielsen CU, Garmer M, Kreilgaard M, Holm R.

Pharm Res. 2015 Mar;32(3):898-909. doi: 10.1007/s11095-014-1505-1. Epub 2014 Sep 3.

PMID:
25182974
15.

The anti-epileptic drug substance vigabatrin inhibits taurine transport in intestinal and renal cell culture models.

Plum J, Nøhr MK, Hansen SH, Holm R, Nielsen CU.

Int J Pharm. 2014 Oct 1;473(1-2):395-7. doi: 10.1016/j.ijpharm.2014.07.023. Epub 2014 Jul 22.

PMID:
25062867
16.

Intestinal absorption of the antiepileptic drug substance vigabatrin in Göttingen mini-pigs is unaffected by co-administration of amino acids.

Nøhr MK, Holm R, Thale ZI, Nielsen CU.

Int J Pharm. 2014 May 15;466(1-2):18-20. doi: 10.1016/j.ijpharm.2014.03.004. Epub 2014 Mar 5.

PMID:
24607206
17.

Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells.

Engelstoft MS, Park WM, Sakata I, Kristensen LV, Husted AS, Osborne-Lawrence S, Piper PK, Walker AK, Pedersen MH, Nøhr MK, Pan J, Sinz CJ, Carrington PE, Akiyama TE, Jones RM, Tang C, Ahmed K, Offermanns S, Egerod KL, Zigman JM, Schwartz TW.

Mol Metab. 2013 Sep 4;2(4):376-92. doi: 10.1016/j.molmet.2013.08.006. eCollection 2013.

18.

The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.

Nøhr MK, Hansen SH, Brodin B, Holm R, Nielsen CU.

Eur J Pharm Sci. 2014 Jan 23;51:1-10. doi: 10.1016/j.ejps.2013.08.034. Epub 2013 Sep 2.

PMID:
24008184
19.

Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.

Nielsen CU, Frølund S, Abdulhadi S, Sari H, Langthaler L, Nøhr MK, Kall MA, Brodin B, Holm R.

Br J Pharmacol. 2013 Nov;170(5):1041-52. doi: 10.1111/bph.12341.

20.

GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.

Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, Sichlau RM, Grunddal KV, Poulsen SS, Han S, Jones RM, Offermanns S, Schwartz TW.

Endocrinology. 2013 Oct;154(10):3552-64. doi: 10.1210/en.2013-1142. Epub 2013 Jul 24.

PMID:
23885020
21.

A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.

Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer EM, Olsen J, Sundler F, Christensen JP, Wierup N, Olsen JV, Holst JJ, Zigman JM, Poulsen SS, Schwartz TW.

Endocrinology. 2012 Dec;153(12):5782-95. doi: 10.1210/en.2012-1595. Epub 2012 Oct 12.

PMID:
23064014

Supplemental Content

Support Center